Press Releases Iqvia Holdings Inc.

Equities

IQV

US46266C1053

Biotechnology & Medical Research

Real-time Estimate Cboe BZX Other stock markets 18:13:51 06/03/2026 GMT			5-day change	1st Jan Change
174.76 ^USD	-2.10%		-2.42%	-22.59%

01:14pm	Argus Research Adjusts IQVIA Holdings PT to $215 From $230, Maintains Buy Rating	MT
12:46pm	Barclays Upgrades IQVIA Holdings to Overweight From Equal Weight, $210 Price Target	MT

Press Releases

03-02	IQVIA CFO to Speak at Barclays 28th Annual Global Healthcare Conference	BU
03-02	IQVIA CEO to Speak at Leerink Partners 2026 Global Healthcare Conference	BU
02-27	IQVIA Releases its 2025 Sustainability Report	BU
02-27	Iqvia : READ OUR 2025 REPORT	PU
02-25	IQVIA Signs Agreement to Acquire Drug Discovery Assets from Charles River Laboratories, Expanding End-to-End Drug Discovery Capabilities	BU
02-18	IQVIA to Speak at Citi's 2026 Unplugged MedTech and Life Sciences Access Day	BU
02-10	IQVIA and Duke Clinical Research Institute Announce Strategic Collaboration to Advance Clinical Research in Obesity and Related Conditions	BU
02-05	Iqvia : Q4 2025 IQVIA Earnings Presentation	PU
02-05	IQVIA: Q4 Earnings Snapshot	AQ
02-05	IQVIA Reports Fourth-Quarter and Full-Year 2025 Results; Issues Full-Year 2026 Guidance	BU
01-29	IQVIA and Boehringer Ingelheim announce strategic long-term global commercial data foundation transformation collaboration	BU
01-23	IQVIA Named to the Fortune(R) World's Most Admired Companies List, Ranked No. 1 in Its Sector for Fifth Consecutive Year	AQ
01-22	IQVIA Named to the Fortune® World’s Most Admired Companies™ List, Ranked No. 1 in Its Sector for Fifth Consecutive Year	BU
01-20	IQVIA to Announce Fourth-Quarter and Full-Year 2025 Results on February 5, 2026	BU
12-10	IFyber Expands Analytical Capabilities with Launch of Advanced LC-MS Services	AQ
12-02	IQVIA Announces Strategic Collaboration with AWS, Naming AWS as Preferred Agentic Cloud Provider to Power Next-Generation AI Platform	BU
11-05	Dr. William G. Kaelin Jr. joins IQVIA Board of Directors	BU
11-03	Thousands of patients from Scotland's poorest areas to benefit from landmark UK government-funded obesity study	AQ
28/10/25	IQVIA: Q3 Earnings Snapshot	AQ
28/10/25	IQVIA Reports Third-Quarter 2025 Results	BU
21/10/25	IQVIA CEO Ari Bousbib to Speak at UBS Global Healthcare Conference on November 11, 2025	BU
08/10/25	Knight Therapeutics Announces Relaunch of ORGOVYX in Canada	AQ
30/09/25	Iqvia : Q3 2025 IQVIA Earnings Presentation	PU
30/09/25	IQVIA to Announce Third-Quarter 2025 Results on October 28, 2025	BU
16/09/25	IQVIA Receives WCG Pinnacle Award for Excellence in Site Relationships	BU